Bullshit right back, there are ample data points to support that the released info in today's PR is not cherry picked data as you keep asserting. Of 40 patients across a dozen types of solid rumors reported so far, 8 ovarian cancer patients showed response to treatment with 4 showing stable disease and one showing remission using RESIST criteria. Overall, of those same 40 patient total, 50% responded to treatment with at least elevations of p21, one of the secondary efficacy outcome measures for the trial. Again in the case of today's report, the one patient treated for a rare tumor, this stage 4 cancer patient is showing stable disease now for 11 months. That's one out of one for this cancer and hardly cherry picked especially in context of the other ~ 20 of 40 who also responded to treatment,